| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. | Director | Common Stock | 6,692 | $196,276 | $29.33 | 10 Jun 2025 | Direct |
| Kezar Life Sciences, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 220,000 | 24 Jul 2023 | Direct | ||
| Avidity Biosciences, Inc. | Director | Stock Option (Right to Buy) | 10,034 | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | 10 Jun 2025 | 2 | $0 | 4 | Director | 12 Jun 2025, 18:42 |
| RNA | Avidity Biosciences, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 18:54 |
| KZR | Kezar Life Sciences, Inc. | 24 Jul 2023 | 8 | $0 | 4 | Chief Medical Officer | 26 Jul 2023, 17:02 |
| RNA | Avidity Biosciences, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:03 |
| KZR | Kezar Life Sciences, Inc. | 08 Jan 2023 | 1 | $0 | 4 | Chief Medical Officer | 10 Jan 2023, 15:55 |
| RNA | Avidity Biosciences, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 20:47 |
| KZR | Kezar Life Sciences, Inc. | 05 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 07 Jan 2022, 16:37 |
| RNA | Avidity Biosciences, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 20:02 |